MUMBAI, May 30 (Reuters) - Indian drugmaker Dr Reddy’s Laboratories Ltd has received tentative approval from the U.S. Food and Drug Administration for omeprazole delayed-release capsules, the regulator’s website showed.
MUMBAI, May 30 (Reuters) - Indian drugmaker Dr Reddy’s Laboratories Ltd has received tentative approval from the U.S. Food and Drug Administration for omeprazole delayed-release capsules, the regulator’s website showed.
